)
)
Travere Therapeutics Investor Relations Material
Latest events
Q3 2024
Travere Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Travere Therapeutics Inc
Access all reports
Travere Therapeutics, Inc. is a biopharmaceutical company focused on the identification, development, and commercialization of therapies for the treatment of rare diseases. Travere Therapeutics Inc., are committed to meeting the needs of patients suffering from rare diseases by developing and providing treatments that have the potential to improve their lives. Incorporated in 2008 with a focus on bringing a pathway to approval for people living with these diseases without treatment options, our clinical portfolio includes several ongoing clinical studies in diseases for which there is no approved therapy.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
TVTX
Country
🇺🇸 United States